96 related articles for article (PubMed ID: 2482482)
1. Expression of phosphorylated and non-phosphorylated neurofilament subunits and cytokeratins in neuroendocrine lung tumors.
Leoncini P; Bellizzi de Marco E; Bugnoli M; Mencarelli C; Vindigni C; Cintorino M
Pathol Res Pract; 1989 Dec; 185(6):848-55. PubMed ID: 2482482
[TBL] [Abstract][Full Text] [Related]
2. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
3. Detection of cytoskeletal proteins in small cell lung carcinoma.
Hlozánková M; Lukás Z; Viklický V
Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin and neurofilament in lung carcinomas.
van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
[TBL] [Abstract][Full Text] [Related]
5. Differentiation markers as an aid in the histological diagnosis of small-cell carcinoma of the lung: synopsis of intermediate filament protein and synaptophysin expression.
Leube RE; Wiedenmann B; Franke WW
Klin Wochenschr; 1988; 66 Suppl 11():80-6. PubMed ID: 2846953
[TBL] [Abstract][Full Text] [Related]
6. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies in lung cancer pathology.
Broers JL; Klein Rot M; de Leij L; Wagenaar SS; Carney DN; Vooijs GP; Ramaekers FC
Eur J Respir Dis Suppl; 1987; 149():11-8. PubMed ID: 2438150
[TBL] [Abstract][Full Text] [Related]
8. Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation.
Bergh J; Nilsson K; Dahl D; Andersson L; Virtanen I; Lehto VP
Lab Invest; 1984 Sep; 51(3):307-16. PubMed ID: 6206304
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
10. Heterotransplantation of small cell lung carcinoma into nude mice. Stability of the phenotypic characters.
Brambilla E; Jacrot M; Batandier C; Brichon PY; Morel F; Nagy-Mignotte H; Paramelle B; Brambilla C
Cancer; 1989 Sep; 64(6):1238-47. PubMed ID: 2475240
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of neurofilament proteins in neuroendocrine neoplasms.
Shah IA; Schlageter MO; Netto D
Mod Pathol; 1991 Mar; 4(2):215-9. PubMed ID: 1646456
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.
Broers JL; Rot MK; Oostendorp T; Huysmans A; Wagenaar SS; Wiersma-van Tilburg AJ; Vooijs GP; Ramaekers FC
Cancer Res; 1987 Jun; 47(12):3225-34. PubMed ID: 2438035
[TBL] [Abstract][Full Text] [Related]
13. Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies.
Broers JL; Carney DN; Klein Rot M; Schaart G; Lane EB; Vooijs GP; Ramaekers FC
J Cell Sci; 1986 Jul; 83():37-60. PubMed ID: 2433295
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
15. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
Broers JL; Ramaekers FC; Rot MK; Oostendorp T; Huysmans A; van Muijen GN; Wagenaar SS; Vooijs GP
Cancer Res; 1988 Jun; 48(11):3221-9. PubMed ID: 2452687
[TBL] [Abstract][Full Text] [Related]
17. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
[TBL] [Abstract][Full Text] [Related]
18. Intermediate filament expression in small cell lung cancer; poor correlation to in vitro data.
Berendsen HH; de Ley L; Poppema S; Postmus PE; Sluiter HJ; The TH
Eur J Respir Dis Suppl; 1987; 149():19-27. PubMed ID: 3034644
[TBL] [Abstract][Full Text] [Related]
19. LKB1 protein expression in neuroendocrine tumors of the lung.
Amin RM; Hiroshima K; Iyoda A; Hoshi K; Honma K; Kuroki M; Kokubo T; Fujisawa T; Miyagi Y; Nakatani Y
Pathol Int; 2008 Feb; 58(2):84-8. PubMed ID: 18199157
[TBL] [Abstract][Full Text] [Related]
20. Divergent differentiation in neuroendocrine lung tumors.
Brambilla E; Lantuejoul S; Sturm N
Semin Diagn Pathol; 2000 May; 17(2):138-48. PubMed ID: 10839614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
